ABI
RDY icon

Adamant Biomedical Investments’s Dr. Reddy's Laboratories RDY Stock Holding History

Adamant Biomedical Investments’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		$2.52M Sell
250,000
-150,000
-38% -$1.58M 0.6% 56
2014
Q3 		$4.2M Buy
+400,000
New +$3.76M 1.05% 37

Other funds holding RDY

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM
BG
BlackRock Group London, United Kingdom $210B AUM 15.76% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
CCM
Causeway Capital Management Los Angeles, California $8.15B AUM 29.28% 1-Year Est. Return

Adamant Biomedical Investments's RDY Position: Q4 2014 in Review

Adamant Biomedical Investments reduced its Dr. Reddy's Laboratories (RDY) stake by 38% in Q4 2014, selling an estimated $1.58M and leaving 250,000 shares worth $2.52M. The position accounts for 0.6% of the portfolio, ranked #56.

Adamant Biomedical Investments first reported a position in RDY in Q3 2014 and has held it in 2 quarters since. The position peaked at $4.2M in Q3 2014. 168 funds tracked by Wall St. Rank hold RDY as of Q4 2014.

  • Adamant Biomedical Investments held 250,000 shares of Dr. Reddy's Laboratories worth $2.52M as of Q4 2014.
  • Adamant Biomedical Investments sold 150,000 Dr. Reddy's Laboratories shares in Q4 2014, an estimated $1.58M.
  • Dr. Reddy's Laboratories made up 0.6% of Adamant Biomedical Investments's portfolio in Q4 2014, its #56 holding.
  • Adamant Biomedical Investments first reported a position in Dr. Reddy's Laboratories in Q3 2014 and has held it in 2 quarters since.
  • Adamant Biomedical Investments's Dr. Reddy's Laboratories position peaked at $4.2M in Q3 2014.
  • 168 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q4 2014.

Based on Adamant Biomedical Investments's 13F filing for Q4 2014, filed 13 Feb 2015.